Positive Efficacy And Tolerability Study Of Repatha® (evolocumab) In Statin-Intolerant Patients Published In Journal of the American Medical Association

Data Simultaneously Presented in Late-Breaking Session at ACC.16Repatha Compared to Ezetimibe Resulted in Significantly Greater Reduction in LDL-C

Amgen - Investors - RSS Content